Sep 2026
OX40 ligand-engineered dendritic cell nanovesicles potentiate antitumor immunity through dual-mode T cell activation.
A ClyA-mediated membrane functionalization strategy provides a versatile tool for engineering cell-derived vesicles, and OX40L-engineered DC nanovesicles offer a promising platform for developing next-generation personalized cancer vaccines.
Zhong-Qian Yang, Yi-Ting Ding, Ying Yang et al.
· Journal of Controlled Releas... · 0 citations